Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma
NCT03381768
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Follicular Lymphoma
Interventions
BIOLOGICAL:
PD-L2 peptide
BIOLOGICAL:
PD-L2 and PD-L1 peptide
Sponsor
Lars Møller Pedersen